Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The IPO Buzz: Cayson Acquisition Prices $60 Million SPAC IPO with Eyes on Asia

% of readers think this story is Fact. Add your two cents.


Cayson Acquisition (CAPNU) priced its small IPO – 6.0 million units at $10.00 each – to raise $60.0 million, as expected, on Thursday night, Sept. 19, 2024. The New York-based SPAC intends to focus its search for target businesses throughout Asia, the prospectus said. Cayson Acquisition is the second SPAC IPO priced this week and the fifth SPAC IPO priced so far in September 2024. At pricing, Cayson Acquisition had a market cap of $78.3 million. The SPAC is incorporated in the Cayman Islands. EarlyBirdCapital was the sole book-runner. Revere Securities was the co-manager. Cayson Acquisition’s IPO is expected to start trading today – Friday, Sept. 20, 2024 – on the NASDAQ. Each unit consists of one share of common stock and one right to receive 1/10 (one-tenth) of a share upon completion of an initial business combination. The company said its search for an Asian business will focus on the following sectors –  financial services, technology, biotech, pharmaceutical, advanced materials and clean energy – the prospectus said. Cayson Acquisition said it “will not consummate our initial business combination with an entity or business with China operations consolidated through a variable interest entity (“VIE”) structure.” “Because our management team has a substantial network in the People’s Republic of China, including, solely for purposes of this prospectus, Hong Kong, Taiwan and Macau, which we refer to throughout this prospectus collectively as the “PRC” or “China”, we may pursue a business combination with a company doing business in China, which may have legal and operational risks associated with such a decision.” Yawei Cao, CEO AND chairman of the board of Cayson Acquisition, is the executive director of Hong Kong Dragon Financial Group, the prospectus said.  Mr. Cao and Cayson Holding LP, an entity affiliated with Cayson Acquisition’s officers and directors, “which we refer to throughout this prospectus as our “sponsors,” have agreed that they and/or their designees will purchase from us an aggregate of 230,000 private units at $10.00 per unit” for $2.3 million in a private placement that will close simultaneously with the IPO, the prospectus said. YHN Acquisition I Raises $60 Million in SPAC IPO Earlier this week, another small SPAC IPO – YHN Acquisition I (YHNAU) – also raised $60 million with identical terms. YHN Acquisition I priced 6.0 million units at $10.00 each on Tuesday night, Sept. 17, 2024. Each unit of this SPAC consisted of share of common stock and one right to receive 1/10 (one-tenth) of a share upon the completion of an initial business combination. YHN Acquisition I’s stock ended flat – at $10.00 – on NASDAQ on Wednesday, Sept 18, 2024. YHN Acquisition I said it has not chosen a region or sector as the focus of its search for an acquisition or business combination target. Instead, YHN Acquisition I said it intends “ to search for businesses with strong management teams.” It is incorporated in the British Virgin Islands. CEO Satoshi Tominaga is the managing partner of Norwich Capital, a financial services firm that focuses on SPACs, the prospectus said. CFO Yangyujia An is the vice chair of Norwich Capital, according to the prospectus. (For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on IPOScoop.com’s website.) Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board. To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message. Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions. Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions or anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.


Source: https://www.iposcoop.com/the-ipo-buzz-cayson-acquisition-prices-60-million-spac-ipo-with-eyes-on-asia/



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.